Study protocol for a pilot, randomised, double-blinded, placebo controlled trial of perineural local anaesthetics and steroids for chronic post-traumatic neuropathic pain in the ankle and foot: the PREPLANS study

Anuj Bhatia, Vera Bril, Richard T Brull, Anthony Perruccio, Duminda Wijeysundera, Sabeeh Alvi, Johnny Lau, Rajiv Gandhi, Nizar Mahomed, Aileen M Davis, Anuj Bhatia, Vera Bril, Richard T Brull, Anthony Perruccio, Duminda Wijeysundera, Sabeeh Alvi, Johnny Lau, Rajiv Gandhi, Nizar Mahomed, Aileen M Davis

Abstract

Introduction: Peripheral neuropathic pain (PNP) associated with trauma is often refractory to treatment. Administration of local anaesthetics (LA) and steroids around injured nerves has been proposed as an option for patients unresponsive to conventional treatments for refractory PNP following trauma. There is insufficient evidence to support a large, potentially expensive, full-scale randomised controlled trial (RCT) that involves comparison of effects of perineural steroids and LA against LA or saline injections on analgesia, physical and psychological functioning, and quality of life. There is also a lack of data that would allow estimation of analgesic efficacy or sample size for the full-scale RCT. The objective of this pilot RCT is to yield information to support planning of a full-scale RCT in this population.

Methods and analysis: 30 participants with post-traumatic PNP in the ankle and foot of moderate-to-severe intensity and duration of more than 3 months will be enrolled in this pilot RCT. Participants will be randomised to receive three ultrasound-guided perineural injections of 0.9% saline, 0.25% bupivacaine (a long-acting LA) or a combination of 0.25% bupivacaine and a steroid (methylprednisolone 16 mg per nerve) at weekly intervals. The primary objectives are to determine the feasibility and sample size of a full-scale RCT in this population. The secondary objectives are to evaluate the effect of study interventions on analgesia, persistence of neuropathic pain, psychological and physical function, quality of life and participants' global impression of change at 1 and 3 months after the interventions. In addition, adverse effects associated with perineural injections and with systemic absorption of steroids will also be recorded.

Ethics and dissemination: The protocol was approved by the University Health Network Research Ethics Board (UHN REB number 15-9584-A). The results will be disseminated in peer-reviewed journals and at scientific conferences.

Trial registration number: NCT02680548; Pre-results.

Keywords: neuropathic pain; perineural; steroids.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Figures

Figure 1
Figure 1
Flow diagram for the pilot RCT. RCT, randomised controlled trial.

References

    1. Reitsma M, Tranmer JE, Buchanan DM et al. . The epidemiology of chronic pain in Canadian men and women between 1994 and 2007: longitudinal results of the National Population Health Survey. Pain Res Manag 2012;17:166–72. 10.1155/2012/875924
    1. Bouhassira D, Lantéri-Minet M, Attal N et al. . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380–7. 10.1016/j.pain.2007.08.013
    1. Toth C, Lander J, Wiebe S. The prevalence and impact of chronic pain with neuropathic pain symptoms in the general population. Pain Med 2009;10:918–29. 10.1111/j.1526-4637.2009.00655.x
    1. Treede RD, Jensen TS, Campbell JN et al. . Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630–5. 10.1212/01.wnl.0000282763.29778.59
    1. Haanpaa M, Treede RD. Diagnosis and classification of neuropathic pain. Pain Clinical Updates 2010;18:1–6.
    1. Moalem G, Tracey DJ. Immune and inflammatory mechanisms in neuropathic pain. Brain Res Rev 2006;51:240–64. 10.1016/j.brainresrev.2005.11.004
    1. Harden RN. Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist 2005;11:111–22.
    1. Attal N, Lanteri-Minet M, Laurent B et al. . The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 2011;152:2836–43. 10.1016/j.pain.2011.09.014
    1. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain 2002;18:355–65. 10.1097/00002508-200211000-00003
    1. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618–25. 10.1016/S0140-6736(06)68700-X
    1. Lander L, Shah RK, Li Y et al. . Healthcare cost usage for hospitalised injuries sustained in industrial settings in the USA. Inj Prev 2013;19:112–18. 10.1136/injuryprev-2011-040166
    1. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23–37. 10.1016/S0014-2999(01)01303-6
    1. Van Zundert J, Hartrick C, Patijn J et al. . Evidence-based interventional pain medicine according to clinical diagnoses. Pain Pract 2011;11:423–9. 10.1111/j.1533-2500.2011.00490.x
    1. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361:184–7. 10.1016/j.neulet.2003.12.007
    1. Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin 2007;45:27–37. 10.1097/AIA.0b013e318034194e
    1. Johansson A, Bennett GJ. Effect of local methylprednisolone on pain in a nerve injury model. A pilot study. Reg Anesth 1997;22:59–65. 10.1016/S1098-7339(06)80057-X
    1. Wang JC, Chiou HJ, Lu JH et al. . Ultrasound-guided perineural steroid injection to treat intractable pain due to sciatic nerve injury. Can J Anaesth 2013;60:902–6. 10.1007/s12630-013-9987-6
    1. Johansson A, Sjölund B. Nerve blocks with local anesthetics and corticosteroids in chronic pain: a clinical follow-up study. J Pain Symptom Manage 1996;11:181–7. 10.1016/0885-3924(95)00167-0
    1. Thomson CE, Beggs I, Martin DJ et al. . Methylprednisolone injections for the treatment of Morton neuroma: a patient-blinded randomized trial. J Bone Joint Surg Am 2013;95:790–8. 10.2106/JBJS.I.01780
    1. Markovic M, Crichton K, Read JW et al. . Effectiveness of ultrasound-guided corticosteroid injection in the treatment of Morton's neuroma. Foot Ankle Int 2008;29:483–7. 10.3113/FAI.2008.0483
    1. Eker HE, Cok OY, Aribogan A et al. . Management of neuropathic pain with methylprednisolone at the site of nerve injury. Pain Med 2012;13:443–51. 10.1111/j.1526-4637.2011.01323.x
    1. Chin KJ, Wong NW, Macfarlane AJ et al. . Ultrasound-guided versus anatomic landmark-guided ankle blocks: a 6-year retrospective review. Reg Anesth Pain Med 2011;36:611–18. 10.1097/AAP.0b013e31822b1291
    1. Tan HL, Bhatia A, Gordon A et al. . A retrospective review of role of pudendal nerve blocks in management of chronic pelvic and urogenital pain. (accessed on 30 July 2014).
    1. Dworkin RH, Turk DC, Wyrwich KW et al. . Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008;9:105–21. 10.1016/j.jpain.2007.09.005
    1. Bhatia A, Flamer D, Shah PS. Perineural steroids for trauma and compression-related peripheral neuropathic pain: a systematic review and meta-analysis. Can J Anaesth 2015;62:650–62. 10.1007/s12630-015-0356-5
    1. Bhatia A, Lau J, Davis AM et al. . Evaluation of efficacy of perineural steroids and local anesthetics for chronic post-traumatic neuropathic pain. Presented as a poster at the 5th International Congress on Neuropathic Pain. France: Nice, 2015. .
    1. Thabane L, Ma J, Chu R et al. . A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1 10.1186/1471-2288-10-1
    1. Chan AW, Tetzlaff JM, Altman DG et al. . SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583
    1. Chan AW, Tetzlaff JM, Gøtzsche PC et al. . SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 2013;346:e7586 10.1136/bmj.e7586
    1. Bouhassira D, Attal N, Alchaar H et al. . Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29–36. 10.1016/j.pain.2004.12.010
    1. Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess 1995;7:524–32. 10.1037/1040-3590.7.4.524
    1. Riazi S, Bril V, Perkins BA et al. . Can ultrasound of the tibial nerve detect diabetic peripheral neuropathy? A cross-sectional study. Diabetes Care 2012;35:2575–9. 10.2337/dc12-0739
    1. Schulz KF, Altman DG, Moher D. Consort 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726–32. 10.7326/0003-4819-152-11-201006010-00232

Source: PubMed

3
Tilaa